INDICATION: Muscular dystrophy...
BCIQ Company Profiles
Harvard Medical School
Yale School of Medicine
BCIQ Target Profiles
Double homeobox 4 (DUX4)
Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Phosphoinositide 3-kinase (PI3K)